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Abstract 
Hepatitis C Virus (HCV) has  infected approximately 2-3% (130-170 million) of the world’s population. No vaccine is available 
to prevent HCV infection. Investigation of anti-HCV agent is thus deemed necessary. Various plants have been explored for their 
anti-HCV activity. A. serratus is a member of Sapindaceae family, which fruit and seed were traditionally used as insecticide. 
Anti-HCV activity tested on A.serratus leaves extract has been done. The result showed that leaves extract exhibited anti-HCV 
with IC50 value of 14.9 ?g/ml and 9.8 ?g/ml against HCV J6/JFH1 and JFH1a, respectively. The cytotoxicity assay results 
showed that A.serratus leaves extract was not toxic and has CC50 >100 ?g/ml. Mode of action experiment results suggested that 
A.serratus extract inhibited HCV at the post-entry step. Further fractionation of leaves extract by open column chromatography 
resulted in 4 fractions. Only Fraction 1 (AP-5F.1) exhibited anti-HCV with IC50 value of 1.2 ?g/ml against HCV JFH1a. 
Separation of AP-5F.1 by open column chromatography resulted in 15 fractions. Fraction number 13 (AP-5F.1.13) exhibited 
anti-HCV with IC50 value of 0.43 ?g/ml against HCV JFH1a. Separation of AP-5F.1.13 by semi preparative-HPLC resulted in 
isolate identified by TLC and LC-MS method as chlorophyll derivate. There was a possibility that chlorophyll derivate has 
participated in performing the anti-HCV activity of fractions and extract besides the other compounds contained. In this study, 
we concluded that A. serratus leaves extract, AP-5F.1, and AP-5F.1.13 exhibited anti-HCV activity against JFH1a virus. 
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Nomenclature 
HCV Hepatitis C Virus   HPLC High Pressure Liquid Chromatography 
IC50  Inhibitory Concentration 50 CC50  Cytotoxicity Concentration 50 
1. Introduction 
Hepatitis C Virus (HCV) has infected approximately 2-3% (130-170 million) of the world’s population. No 
vaccine is available to prevent HCV infection. Treatment for HCV has been developed and rapidly evolving. 
However, several obstacles remain in the current treatment of HCV1. Development of anti-HCV agent is thus 
deemed  necessary. Various plants have been explored for their anti-HCV activity. Anti-HCV activity screening of 
21 samples from 17 species of medicinal plants explored in the East Java Region, Indonesia revealed that extract of 
Toona sureni leaves (TSL), Melicope latifolia leaves (MLL), Melanolepis multiglandulosa stem (MMS), Ficus 
fistulosa leaves (FFL) showed antiviral activity with IC50 value at a range of 2.0 – 17.1 μg/ml. Time of addition 
experiments revealed that TSL and MLL inhibited both at the entry and post-entry steps, while MMS and FFL 
principally at the entry step2. Several numbers of isolated compounds were also reported to exhibit antiviral activity 
against HCV.  
Glycycoumarin, glycyrin, glycyrol and liquiritigenin isolated from Glycyrrhiza uralensis were identified as anti-
HCV compounds with IC50 value of 8.8, 7.2, 4.6 and 16.4 μg/ml, respectively. Those compounds acted on the post-
entry step3. Quercetin and gallic acid isolated from Kalanchoe pinnata also inhibited HCV production in a dose-
dependent manner, with IC50 value of 1.5 and 6.1 μg/ml, respectively, without exhibiting cytotoxicity. Quercetin 
acts at the post-entry step, whereas gallic acid at both the entry and post-entry steps4. In this study, the anti-HCV 
activity of Alectryon serratus has been determined.  A. serratus is a member of Sapindaceae family, which fruit and 
seed were traditionally used as insecticide. It was  reported that A.serratus leaves extract has antimalarial activity 
with IC50 value of 12.3 ?g/ml and antioxidant activity with IC50 value of 1.96 ?g/ml5,6, but no reference was found 
regarding the antiviral activity of this plant. This study aims to determine the active substances of A.serratus extract 
which play a role in anti-HCV activity. 
2. Methods 
2.1. Plant material 
Alectryon serratus leaves were collected from Alas Purwo National Park, Banyuwangi, East Java, Indonesia. 
Authentication and identification of plant were carried out at The Purwodadi Botanical Garden, East Java. 
2.2. Extraction and fractionation 
Leaves of A.serratus were dried at room temperature and pulverized. Dried leaves powder were extracted using 
ethanol 80% as solvent by ultrasonic assisted extraction for two minutes to three times replications. The ethanol 
extract was filtered and the obtained filtrates were concentrated using rotary evaporator to obtain ethanol extract of 
A.serratus (AP-5F). Further separation of AP-5F was done by open column chromatography using  silica gel as 
stationary phase and gradient of chloroform-methanol system as development solvent. The separation resulted in 4 
fractions (AP-5F.1–4) which were later continued for bioassay. A bioactivity-active fraction(s) was further 
fractionated under open column chromatography with sephadex LH-20 and 90% mobile phase methanol. The 
separation of AP-5F.1 resulted in 15 fractions (AP-5F.1.1-1.15). AP-5F.1.13 was further separated by semi 
preparative HPLC (solvent system: acetonitrile-methanol-water 75:2.5:22.5, column: Water XBridge 10x250 mm 
5μm, flowrate: 2.5 ml/min, detection UV 365 nm). 
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2.3. Cells and viruses 
Huh7it cells were cultivated in Dulbecco’s modified Eagle’s medium supplemented with fetal bovine serum, non 
essensial amino acids, penicillin and streptomycin. Cells were grown at 37°C in a 5% CO2 incubator.  
2.4. Analysis of anti-HCV activities 
A.serratus extract and fractions were dissolved in dimethyl sulfoxide (DMSO) to obtain stock solutions at a 
concentration of 100 mg/ml. The stock solutions were stored at -20°C until it was used. 
Analysis of anti-HCV method was described previously7. Huh7it cells were seeded in 24-well plates (5×104 
cells/well). A fixed amount of JFH1a, with multiplication of infection (MOI) of 0.1 focus-forming units (ffu)/cell, 
was mixed with serial dilutions of the extracts (100, 50, 25, 12.5, 6.25 and 3.1 μg/ml) and inoculated to the cells. 
After 2 hours, the cells were washed with medium to remove the residual virus and further incubated in the medium 
containing the same concentrations of the test samples as those during virus inoculation. 
Time of addition experiments were performed to assess the mode of action of the samples. Three sets of 
experiments were done in parallel: (i) to assess the antiviral effect at the entry step, the mixture of HCV and sample 
was inoculated to the cells. After virus adsorption for 2 hours, the residual virus and the sample were removed, and 
cells were refed with fresh medium without the sample for 46 hours; (ii) to assess the antiviral effect at the post-
entry step, HCV was inoculated to the cells in the absence of the sample. After virus adsorption for 2 hours, the 
residual virus was removed and cells were refed with fresh medium containing the sample for 46 hours; (iii) as a 
positive control, HCV mixed with the sample was inoculated to the cells8. After virus adsorption for 2 hours, the 
residual virus and the sample were removed, and cells were refed with fresh medium containing the sample for 46 
hours. Culture supernatants were obtained at 1 and 2 days post-infection (dpi) and titrated for virus infectivity. Virus 
and cells treated with medium containing 0.1% DMSO served as a control. The inhibition percentage of virus 
infectivity by the samples were calculated by comparing to the control using SPSS probit analysis, and IC50 values 
were determined. 
2.5. Cytotoxicity assay 
The cytotoxicity of the samples was assessed by MTT assay. Huh7it  cells in 96 well plates were treated with 
serial dillution of the samples or control. The condition of the cells was observed after 46 hours incubation and the 
toxicity was checked under microscope. The medium was removed from 96 well plates and then MTT 10% 150 
μl/well was put by multichannel pipette and incubated for 4 hours at 37°C. MTT solution was removed from 96 well 
plates and 100?l/well DMSO 100% was then put for dissolve. Absorbance was checked at 560 nm and 750 nm, 
shaker 0.5 min before reading absorbance. 
3. Results and discussion 
Anti-HCV activity screening of A.serratus leaves and stem extract revealed that leaves extract exhibited anti-
HCV with IC50 value of 14.9 ?g/ml and 9.8 ?g/ml against HCV J6/JFH1 and JFH1a, respectively. The cytotoxicity 
assay results showed that A.serratus leaves extract has CC50 >100 ?g/ml (Table 1). Mode of action experiment 
results suggested that A.serratus extract inhibited HCV at the post-entry step (Table 2). 
 
Table 1. Anti-HCV activity of extract and fractions of A.serratus 
Sample IC50 (μg/ml) CC50 (μg/ml) 
AP-5F 14.9* >100* 
AP-5F 9.8 347.21 
AP-5F.1 1.2 27.95 
AP-5F.1 <10* >100* 
AP-5F.1.3 78.93  
AP-5F.1.9 NA  
AP-5F.1.13 0.43 39.73 
All samples were tested against JFH1a, except for * was tested against J6/JFH1. 
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 Table 2. Time of addition analysis of A.serratus extract (AP-5F) 
Replicate  IC50 (μg/ml) Mode of action 
During+post 
inoculation 
During inoculation Post inoculation 
1 6.25 11.3 6.25 Post-entry 
inhibition 2 5.5 20.1 7.9 
3 9.5 22.6 10.7 
 
Further fractionation of leaves extract by open column chromatography resulted in 4 fractions. Only Fraction 1 
(AP-5F.1) exhibited anti-HCV with IC50 value of 1.2 ?g/ml against HCV JFH1a. Separation of AP-5F.1 by open 
column chromatography using sephadex LH-20 as stationary phase and methanol 90% as mobile phase resulted in 
15 fractions (AP-5F.1.1 – 1.15). Thin layer chromatography (TLC) profile of fractions is shown in Fig. 1. 
 
 
Fig. 1. TLC profile of fraction AP-5F.1.1 – 1.15 (15 fractions), detected under UV 254 nm (a), UV 365 nm (b) 
 
Fraction number 13 (AP-5F.1.13) exhibited anti-HCV with IC50 value of 0.43 ?g/ml against HCV JFH1a. On the 
TLC analysis (detection UV 365 nm) of AP-5F.1.13, a red fluorescent spot was detected. This results suggested that 
AP-5F.1.13 consists of chlorophyll compounds. Separation of AP-5F.1.13 by semi preparative-HPLC (solvent 
system: acetonitrile-methanol-water 75:2.5:22.5, column: Water XBridge 10x250 mm 5μm, flowrate: 2.5 ml/min, 
detection UV 365 nm) resulted in isolate identified by TLC and Liquid Chromatography-Mass Spectra (LC-MS) 
method as chlorophyll derivate. There was a possibility that chlorophyll derivate has participated in performing the 
anti-HCV activity of fractions and extract besides the other compounds contained. This suggestion was confirmed 
by previous study. It was reported that pheophorbide a and pyropheophorbide a, isolated from Morinda citrifolia 
showed potent anti-HCV activities with IC50 of 0.3 and 0.2 μg/ml, respectively9. Therefore, further purification is 
still required to isolate and identify the pure chlorophyll compounds that take a role in anti-HCV activity. 
4. Conclusion 
In this study, we concluded that A. serratus leaves extract (AP-5F), fraction AP-5F.1, and fraction AP-5F.1.13 
exhibited anti-HCV activity against JFH1a virus. 
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